Descriptively quantitative relationship between mutated N-acetylgalactosamine-6-sulfatase and mucopolysaccharidosis IVA.
To study the quantitative relationship between the mutant N-acetylgalactosamine-6-sulfatase and the occurrence of mucopolysaccharidosis IVA, the human N-acetylgalactosamine-6-sulfatase with 117 mutations was quantified using the amino-acid distribution probability, then the mutations and clinical outcomes were coupled using the cross-impact analysis. The results show that a patient has 0.94 chance of being mucopolysaccharidosis IVA when a new mutation occurs in N-acetylgalactosamine-6-sulfatase.